Petros Pharmaceuticals
PTPI
PTPI was delisted on the 21st of May, 2025.
18 hedge funds and large institutions have $3.58M invested in Petros Pharmaceuticals in 2021 Q4 according to their latest regulatory filings, with 10 funds opening new positions, 4 increasing their positions, 3 reducing their positions, and 8 closing their positions.
232% more call options, than puts
Call options by funds: $206K | Put options by funds: $62K
96% more capital invested
Capital invested by funds: $1.82M → $3.58M (+$1.76M)
33% more repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 3
25% more first-time investments, than exits
New positions opened: 10 | Existing positions closed: 8
13% more funds holding
Funds holding: 16 → 18 (+2)
0.01% less ownership
Funds ownership: 0.03% → 0.02% (-0.01%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SSA
Schonfeld Strategic Advisors
New York
|
+$804K |
| 2 |
Marshall Wace
London,
United Kingdom
|
+$572K |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$159K |
| 4 |
VF
Virtu Financial
New York
|
+$124K |
| 5 |
State Street
Boston,
Massachusetts
|
+$104K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SC
Shay Capital
New York
|
-$555K |
| 2 |
NP
NorthRock Partners
Minneapolis,
Minnesota
|
-$431K |
| 3 |
CM
CM Management
Gulf Breeze,
Florida
|
-$200K |
| 4 |
Renaissance Technologies
New York
|
-$109K |
| 5 |
PTP
Platform Technology Partners
New York
|
-$88K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
26
Royal Bank of Canada
Toronto,
Ontario, Canada
| – | -$4.69K | -8 | Closed |
|
PTPI Hedge Fund Activity: Q4 2021 in Review
18 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in Petros Pharmaceuticals (PTPI) for Q4 2021, worth a combined $3.58M — up 96% from $1.82M a quarter earlier.
Buyers outnumbered sellers: 10 funds opened new PTPI positions and 8 closed out — a net gain of 2 holders — while 4 added to existing stakes and 3 trimmed.
The largest buyer was Schonfeld Strategic Advisors, opening a new position worth an estimated $804K. The largest seller was Shay Capital, exiting entirely with an estimated $555K sold.
- 18 institutional investors held Petros Pharmaceuticals (PTPI) as of Q4 2021, up from 16 in Q3 2021.
- Funds reported $3.58M of Petros Pharmaceuticals stock for Q4 2021, up 96% quarter-over-quarter.
- 10 funds opened new Petros Pharmaceuticals positions in Q4 2021 and 8 closed out, a net change of +2 holders.
- The largest Petros Pharmaceuticals buyer in Q4 2021 was Schonfeld Strategic Advisors, an estimated $804K added.
- The largest Petros Pharmaceuticals seller in Q4 2021 was Shay Capital, an estimated $555K sold.
Based on aggregated 13F filings for Q4 2021.